The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It

The company plans to add telemedicine capabilities to its verified health-intelligence platform and has opened a 10-seat Founding Physician Cohort. The initiative will focus on GLP-1 and metabolic care, hormone and menopause health, and physician-directed therapies for men and women. The announcement signals product expansion in digital healthcare but provides no financial targets, revenue impact, or launch timeline.